BusinessNETWIRE: Morning Stocks in the News: WTWO, ALTI, FNIN, LH

Fri. June 20, 2008; Posted: 10:07 AM

BusinessNetWire is an affiliate of Stock Profiler.US, LLC, who welcomes Investors and Companies alike to join us in our pursuit of excellence. Companies who want to broadcast their message are encouraged to contact us at www.stockprofiler.us. Sign up for our Free Newsletter at www.stockprofiler.us.

-------------------------------------------

W2 Energy Inc. (PINKSHEETS: WTWO | Quote | Chart | News | PowerRating) (FRANKFURT: WJD) closed at $0.06 Thursday, trading 507,066 shares.

Company News- June 18, 2008: W2 Energy Inc. to Pursue Biodiesel Market

W2 Energy Inc. (PINKSHEETS: WTWO | Quote | Chart | News | PowerRating) (FRANKFURT: WJD), a waste-to-energy and renewable energy company, announced Wednesday its entry into the biodiesel market. W2 Energy builds waste-to-energy plants which convert municipal solid waste, tires, agricultural waste, human waste and coal into electricity and syndiesel. "We can take our syndiesel, mix it with biodiesel, and make high quality diesel with excellent lubricity and temperature specifications," says Mike McLaren, CEO of W2 Energy. "We can also produce methanol with our waste-to-energy plants. The cost of methanol keeps going up. We can make our own methanol for biodiesel production and make biodiesel less expensively than the competition." For its biodiesel operations, W2 will not use food as feed products or feedstock. "We will use jatropha, other non-food vegetable oils and waste vegetable oils," says Mike McLaren. "W2 will not make fuel out of food. It's our policy." W2 Energy's new fuel blend of syndiesel and biodiesel will have specifications equal to or better than today's B20 using petroleum products. W2 Energy seeks joint venture partners with and without existing biofuels production capabilities. W2 also seeks producers of Jatropha, Algae and Waste vegetable oils who can commit to long term contracts. "We believe we have great technology and a marketplace hungry for an all renewable, non-food, diesel product. Now we are looking for the right companies to share our vision," added Mike McLaren. According to the Commission of the European Communities, the EU consumed approximately 874 million gallons of biodiesel in 2005 (a 1.6% share of the EU diesel market), 1.6 billion gallons in 2006 (2.6% of the market), and according to the USDA, is projected to consume 3.0 billion gallons (3.0% of the market) in 2008.

About W2 Energy Inc.

W2 Energy Inc. is a growing, publicly traded company that develops renewable energy technologies and applies it to new generation power systems. Specifically, W2 Energy Inc.'s plasma assisted biomass to energy plants utilize state of the art technologies to produce green energy both fuel (sulfur free diesel) and electricity at the most efficient cost in capital investment and production per/barrel, per/Megawatt.

-------------------------------------------

Altair Nanotechnologies Inc. (NASDAQ: ALTI | Quote | Chart | News | PowerRating) closed at $2.09 Thursday, trading 415,200 shares.

Company News- June 20, 2008: Terry Copeland Appointed President and Chief Executive Officer of Altair Nanotechnologies

Altair Nanotechnologies Inc. (NASDAQ: ALTI), a leading provider of advanced nanomaterials technology for use in energy, life sciences and industrial applications, announced earlier today that its Board of Directors has appointed Terry Copeland, Ph.D., as its President and Chief Executive Officer. Dr. Copeland has been serving as interim President since March 2008. "Terry's understanding of the company's personnel, products and market opportunities, combined with the breadth of his management expertise, make him the best choice to lead Altair Nanotechnologies in its next phase of growth," said Altair Board Chairman Jon N. Bengtson. "During the past 10 weeks, Terry and his newly formed executive team have reviewed the company's strategy, products and business units to assure Altair's proper positioning within its marketplaces. During this process Terry demonstrated in-depth industry knowledge, high ethical standards, and a collaborative leadership style." Dr. Copeland joined Altair Nanotechnologies in November 2007 in the role of Vice President, Operations for Altair's Power and Energy Group. His duties included leading global operations and supply chain management for Altair's lithium titanate battery and stationary power products. "I am pleased to have the Board's confidence and am enthusiastic about continuing to lead Altair," commented Dr. Copeland. "The Board and management team have a solid understanding of both the challenges and growth opportunities that lie ahead. I am confident that Altair has the people, technology and business plan to drive the commercialization of the company's power and energy products, as well as those in life sciences and performance materials." The company also announced the appointment of C. Robert Pedraza as Vice President, Corporate Strategy and a member of the executive management team. Prior to joining Altair Nanotechnologies, Dr. Copeland was the founder of T.M. Copeland Associates, an engineering, technology and operations consulting firm. Prior to founding Copeland Associates, he served as Vice President of Product Development, and Research and Development for Millennium Cell, Inc., an alternative energy company. Dr. Copeland spent much of his career with Duracell. He joined the company in 1992 as Director of Engineering for North America, and was responsible for the program leading to the development and commercialization of Duracell's on-cell battery tester. During his tenure with Duracell, he was credited with the turnaround of an ailing manufacturing facility in North Carolina and went on to lead Duracell's largest plant in North America, with over 1,000 employees. When Gillette acquired the company, Dr. Copeland relocated to Boston as the company's Director of Product Development. Dr. Copeland began his professional career with the DuPont Company in research and development at the company's Experimental Station in Wilmington, DE. His successes at DuPont led to roles in international marketing and manufacturing, and resulted in his appointment as Manufacturing Manager responsible for the output of several plants in North America. Dr. Copeland graduated from the University of Delaware with a B.S. in Chemical Engineering. He earned a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology, with a minor in law.

ABOUT ALTAIR NANOTECHNOLOGIES INC.

Altairnano is an innovator and supplier of advanced novel, ceramic nanomaterials. A seasoned management team complements Altairnano's leading edge scientists, with substantial experience in commercializing innovative, disruptive technologies. The company has developed nanomaterials for the alternative energy, life sciences and performance materials markets based on its proprietary manufacturing process. This process also provides the foundation for its innovative AHP pigment process. For more information visit: www.altairnano.com.

-------------------------------------------

Financial Industries Corporation (PINKSHEETS: FNIN | Quote | Chart | News | PowerRating) closed at $6.82 Thursday, trading 100 shares.

Company News- June 19, 2008: Financial Industries Corporation, Americo Extend Merger Closing Date

Financial Industries Corporation (PINKSHEETS: FNIN | Quote | Chart | News | PowerRating) announced earlier today that it has agreed with Americo Life, Inc. to extend the date to complete their expected merger to July 18. The extension letter, signed yesterday, is to allow for an additional regulatory approval that is expected to be received by July 18, at which time the closing will occur.

About FIC

FIC, through its Investors Life Insurance Company of North America subsidiary, administers a closed block of individual life insurance and annuity products. For more information on FIC, visit www.ficgroup.com on the Internet.

-------------------------------------------

Laboratory Corporation of America Holdings (NYSE:LH) closed at $71.49 Thursday, trading 1,022,400 shares.

Company News- June 20, 2008: LabCorp is Scheduled to Present at the Jefferies 2nd Annual Healthcare Conference

Laboratory Corporation of America Holdings (LabCorp) (NYSE:LH) announced earlier today that David P. King, Chief Executive Officer and Bradford T. Smith, Executive Vice President, Corporate Affairs, are scheduled to speak at the Jefferies 2nd Annual Healthcare Conference in New York City, NY. LabCorps presentation is planned for Tuesday, June 24, 2008 at 8:30 a.m. (Eastern Time). A live audio webcast of the presentation will be available via the Company Web site at www.labcorp.com and archived for replay.

About LabCorp

Laboratory Corporation of America Holdings, a S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $4.1 billion in 2007, over 26,000 employees nationwide, and more than 220,000 clients, LabCorp offers clinical assays ranging from routine blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, National Genetics Institute, Inc., ViroMed Laboratories, Inc., The Center for Esoteric Testing, DIANON Systems, Inc., US LABS, and Esoterix and its Colorado Coagulation, Endocrine Sciences, and Cytometry Associates laboratories. LabCorp conducts clinical trial testing through its Esoterix Clinical Trials Services division. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our organization, visit our Web site at: www.labcorp.com.

-------------------------------------------

The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BusinessNetwire.US affiliates has not been compensated for services rendered; BusinessNetwire.US affiliates is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers, go to http://www.businessnetwire.us) (disclaimers).

CONTACT: BusinessNetwire.US e-mail: info@ businessnetwire.us WWW: http://www.businessnetwire.us/

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details for ALTI click here.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index